Search tickers (stock/ETF/mutual fund)...
  • Screener
  • Watchlist
  • Charts
  • Gurus
  • Copilot
    Filings Search  
    Plans   
    Login   
    Register   
    Backtest Portfolio
    Portfolio Optimization
    Asset Correlations
    Efficient Frontier

    BSEM Gross Margin

    As of 2025-05-24, the Gross Margin of Biostem Technologies Inc (BSEM) is 95.5%.

    Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

    BSEM Gross Margin - Historical Value
    DateValue
    2024-12-31 95.5%
    2023-12-31 92.4%
    2021-12-31 65%
    2020-12-31 49.6%
    2017-12-31 54.5%
    2016-12-31 37.1%
    2011-12-31 62.7%
    2010-12-31 75%
    1999-12-31 43.9%
    1998-12-31 -
    BSEM Gross Margin - Peers Comparison
    TickerNameValue
    AQS.VAequus Pharmaceuticals Inc56.4%
    AVCR.VAvricore Health Inc39.3%
    BSPKBespoke Extracts Inc43.7%
    CBDXCurative Biosciences Inc34.8%
    CHM.CNChemistree Technology Inc25.5%
    CPMDCannaPharmaRx Inc21%
    CVGR.CNCity View Green Holdings Inc23.2%
    ERBBAmerican Green Inc7775.2%
    EXM.CNExmceuticals Inc7775.2%
    GNOM.CNGnomestar Craft Inc-56.9%
    IPCI.TOIntellipharmaceutics International Inc100%
    KAYSKaya Holdings Inc58.6%
    KOANResonate Blends Inc-593%
    MJ.CNMaven Brands Inc45.8%
    MLCL.CNMolecule Holdings Inc-54.6%
    MPXI.CNMPX International Corp65.4%
    NGBLNotis Global Inc-5.6%
    NOUVNouveau Life Pharmaceuticals Inc7775.2%
    NXENNexien Biopharma Inc16.6%
    PLSIPhoenix Life Sciences International Ltd27.1%
    POT.CNPotent Ventures Inc6%
    RSPIRespireRx Pharmaceuticals Inc7775.2%
    SNESSenestech Inc54.1%
    SPR.CNSproutly Canada Inc-107.4%
    SUGR.VSugarBud Craft Growers Corp13%
    VIV.VAvivagen Inc42.6%
    Tickers added to watchlist